Organogenesis this week said it appointed David Francisco as the company’s chief financial officer, effective Feb. 15.
Francisco replaces Henry Hagopian, who will move on to become the company’s senior VP of finance and treasurer.
“I am pleased to welcome Dave to the Organogenesis executive leadership team,” president and CEO Gary Gillheeney said in a news release. “Dave brings strong strategic, financial, and operational leadership across multiple business areas and over 25 years of finance and accounting experience. I look forward to working with Dave as we continue to execute on our strategy to drive growth and improve profitability while delivering on our mission to substantially improve medical outcomes and lower the overall cost of care.”
Prior to joining the company, Francisco held leadership roles at PerkinElmer.
“Organogenesis is an impressive organization with compelling growth opportunities,” Francisco said. “I am excited to join the Company at a time that I believe represents an important inflection point in its history and look forward to partnering with Gary and the rest of the executive leadership team to deliver strong operational and financial performance.”